Skip to main content

HIV | GileadPro

HIV-Medication-Access

HIV Medication Access

For more than a decade, Gilead Sciences has been a leader in the development of antiretroviral therapies for HIV/AIDS. Gilead researchers have developed 11 commercially available HIV medications and are advancing a robust pipeline of next-generation therapeutic options.

Events_Banner
Upcoming events

HIV Events

Here you will find an overview of events and congresses in HIV

Access the reserved area to find out more

Reference

  1. 1. World Health Organization. HIV/AIDS. Available at: https://www.who.int/news-room/facts-in-pictures/detail/hiv-aids
CH-UNB-0499, 12/25